Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or... – Recovery or purification
Reexamination Certificate
2007-06-26
2007-06-26
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
Recovery or purification
C435S069100, C435S070100, C435S325000, C435S320100, C435S235100, C536S023720, C536S024100
Reexamination Certificate
active
10704407
ABSTRACT:
The present invention relates to the determination of an authentic HCV genome RNA sequences, to construction of infectious HCV DNA clones, and to use of the clones, or their derivatives, in therapeutic, vaccine, and diagnostic applications. The invention is also directed to HCV vectors, e.g., for gene therapy of gene vaccines.
REFERENCES:
patent: 4631211 (1986-12-01), Houghten
patent: 5010175 (1991-04-01), Rutter et al.
patent: 5077193 (1991-12-01), Mishiro et al.
patent: 5106726 (1992-04-01), Wang
patent: 5176994 (1993-01-01), Mishiro et al.
patent: 5218099 (1993-06-01), Reyes et al.
patent: 5298394 (1994-03-01), Arima et al.
patent: 5312737 (1994-05-01), Bolling et al.
patent: 5350671 (1994-09-01), Houghten et al.
patent: 5371017 (1994-12-01), Houghton et al.
patent: 5372928 (1994-12-01), Miyamura et al.
patent: 5378814 (1995-01-01), Houghton et al.
patent: 5389528 (1995-02-01), Houghton et al.
patent: 5427909 (1995-06-01), Okamoto et al.
patent: 5428145 (1995-06-01), Okamoto et al.
patent: 5436126 (1995-07-01), Wang
patent: 5443965 (1995-08-01), Reyes et al.
patent: 5527669 (1996-06-01), Resnick et al.
patent: 5538865 (1996-07-01), Reyes et al.
patent: 5550016 (1996-08-01), Okamoto
patent: 5552310 (1996-09-01), Yoshikura et al.
patent: 5563328 (1996-10-01), Mitra et al.
patent: 5576302 (1996-11-01), Cook et al.
patent: 5580718 (1996-12-01), Resnick et al.
patent: 5585258 (1996-12-01), Houghton et al.
patent: 5597691 (1997-01-01), Houghton et al.
patent: 5610054 (1997-03-01), Draper
patent: 5620843 (1997-04-01), Hellings et al.
patent: 5625034 (1997-04-01), Liao et al.
patent: 5625043 (1997-04-01), Priebe et al.
patent: 5641654 (1997-06-01), Maki et al.
patent: 5645983 (1997-07-01), Liao et al.
patent: 5654179 (1997-08-01), Lin
patent: 5656731 (1997-08-01), Urdea
patent: 5661008 (1997-08-01), Almstedt et al.
patent: 5667992 (1997-09-01), Casey et al.
patent: 5670152 (1997-09-01), Weiner et al.
patent: 5670153 (1997-09-01), Weiner et al.
patent: 5677124 (1997-10-01), DuBois et al.
patent: 5679342 (1997-10-01), Houghton et al.
patent: 5683864 (1997-11-01), Houghton et al.
patent: 5698390 (1997-12-01), Houghton et al.
patent: 5712088 (1998-01-01), Houghton et al.
patent: 5714596 (1998-02-01), Houghton et al.
patent: 5854067 (1998-12-01), Newgard et al.
patent: 5874565 (1999-02-01), Rice et al.
patent: 6127116 (2000-10-01), Rice et al.
patent: 6153421 (2000-11-01), Yanagi et al.
patent: 6165715 (2000-12-01), Collins et al.
patent: 6392028 (2002-05-01), Rice et al.
patent: 6630343 (2003-10-01), Bartenschlager
patent: 1 267 167 (2002-12-01), None
patent: WO96/34976 (1996-11-01), None
patent: WO97/08310 (1997-03-01), None
patent: WO99/04008 (1999-01-01), None
patent: WO01/89364 (2001-11-01), None
Blight et al., Science, vol. 290 No. 5498, pp. 1972-1974 (Dec. 2000).
Bowie et al., Science, vol. 247 No. 4948, pp. 1306-1310 (Mar. 1990).
Friebe et al., Journal of Virology, vol. 76 No. 11, pp. 5326-5338 (Jun. 2002).
Ito et al., Journal of Virology, vol. 72 No. 11, pp. 8789-8796 (Nov. 1998).
Lohmann et al., Science, vol. 285 No. 5424, pp. 110-113 (Jul. 1999).
Tanaka et al., Journal of Virology, vol. 70 No. 5, pp. 3307-3312.
Umlauft et al., Journal of Clinical Microbiology, vol. 34 No. 10, pp. 2552-2558 (Oct. 1996).
Yi et al., Journal of Virology, vol. 77 No. 6, pp. 3557-3568 (Mar. 2003).
Yoo et al., Journal of Virilogy, vol. 69 No. 1, pp. 32-38 (Jan. 1995).
Lohmann et al., Science, vol. 285 No. 5424, pp. 110-113 (Jul. 1999).
Tanaka et al., Journal of Virology, vol. 70 No. 5, pp. 3307-3312 (1996).
Umlauft et al., Journal of Clinical Microbiology, vol. 34 No. 10, pp. 2552-2558 (Oct. 1996).
Yi et al., Journal of Virology, vol. 77 No. 6, pp. 3557-3568 (Mar. 2003).
Verma et al., “Gene Therapy—Promises, Problems and Prospects”, Nature, vol. 389, pp. 239-242 (1997).
Eck et al., “Gene-Based Therapy”, The Pharmacological Basis of Therapeutics, Goodman and Gilman, Eds., pp. 77-101 (1996).
Orkin et al., “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH (1995). Online at www.nih.gov
ews/panelrep.html.
Houdebine, “Production of Pharmaceutical Proteins From Transgenic Animals”, Journal of Biotechnology, vol. 34, pp. 269-287 (1994).
Lanford et al., “Advances in Model Systems for Hepatitis C Virus Research”, Virology, vol. 293 No. 1, pp. 1-9 (Feb. 2002).
Zhu et al., “Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells”, Journal of Virology, vol. 77 No. 17, pp. 9204-9210 (Sep. 2003).
Grobler et al., “Identification of a Key Determinant of Hepatitis C Virus Cell Culture Adaptation in Domain II of NS3 Helicase”, The Journal of Biological Chemistry, vol. 278 No. 19, pp. 16741-16746 (May 2003).
Blight et al., “Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication”, Journal of Virology, vol. 76 No. 24, pp. 13001-13014 (Dec. 2002).
Chung et al., “Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system”, Proceedings of the National Academy of Sciences, USA, vol. 98 No. 17, pp. 9847-9852 (Aug. 2001).
Bartenschlager et al., “Replication of the hepatitis C virsus in cell culture”, Antiviral Research, vol. 60 No. 2, pp. 91-102 (Oct. 2003).
Patent Cooperation Treaty; International Search Report; Jan. 3, 2005.
Barton and Flanegan, “Coupled translation and replication of poliovirus RNA in vitro: synthesis of functional 3D polymerase and infectious virus”,J. Virol.67:822-831 (1993).
Blight et al., “Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology”,Amer. J. Path.143:1568-1573 (1993).
Boyer et al., “Pathogenesis, diagnosis and management of hepatitis C”,J. Hepatol.32(1 Suppl.) 98-112 (2000).
Bredenbeek et al., “Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs”,J. Virol.67:6439-6446 (1993).
Butkiewicz et al., “Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3”,J. Virol.74, 4291-4301 (2000).
Carloni et al., “Susceptibility of human liver cell cultures to hepatitis C virus infection”,Arch. Virol.(1993) [Suppl] 8:31-39.
Farci et al., “The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies”,Science288:339-344 (2000).
Frolov et al., “Selection of RNA replicons capable of noncytopathic replication in mammalian cells”,J. Virol., 73:3854-3856 (1999).
Gale et al., “Evidence That Hepatitis C Virus Resistance to Interferon Is Mediated Through Repression of the PKR Protein Kinase by the Nonstructural 5A Protein,”Virology230, 217-227 (1997).
Ghosh et al., “Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP”,J. Biol. Chem.275:7184-7188 (2000).
Honda et al., “Natural variation in translational activities of the 5′ nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site”,J. Virol.73:4941-4951 (1999).
Hutchison et al., “A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus”,Proc. Nat'l. Acad. Sci.USA 83:710-714 (1986).
Jansen et al., “Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication,”Virology163:299-307 (1988).
Kolykhalov et al., “Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA”,Science277:570-574 (1997).
Krieger et al., “Enhancement of Hepatitis C Virus RNA replication by cell culture-adaptive mutations”,J. Virol.75:4614-4624 (2001).
Lai,Hepatology 27:299-302 (1998
Kolykhalov Alexander A.
Rice Charles M.
Campell Bruce R.
Lucas Zacharaiah
Thompson & Coburn LLP
Washington University
LandOfFree
Functional DNA clone for hepatitis C virus (HCV) and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functional DNA clone for hepatitis C virus (HCV) and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functional DNA clone for hepatitis C virus (HCV) and uses... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3814143